On April 13th, S.3971 – the Small Business Innovation and Economic Security Act was signed by President Trump, providing a 5-year reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs and ending a 6-month funding delay. Often called “America’s Seed Fund”, the programs provide non-dilutive, equity-free funding to early-stage technology based small businesses working to commercialize research and development.
This reauthorization introduces changes to the ecosystem, addressing concerns previously raised about the program.
Foreign Influence & National Security Risks
The most impactful changes within the bill cover three areas: foreign influence & national security, rules & limitations for repeat awardees, and performance expectations for commercialization. The final version of S.3971 makes national security reviews mandatory and prohibits grants being awarded to companies with specific foreign ties. Companies applying for SBIR/STTR’s will now have to be noticeably clear on their ownership, the origin of capital investment, who controls their IP and what foreign affiliation their talent has.
Participation of “Multiple Award Winners”
The final version of S. 3971 addresses concerns about the concentration of awards among a small number of firms by introducing measures to broaden participation while preserving program effectiveness. It strengthened oversight to ensure that companies demonstrate meaningful progress toward commercialization, thereby discouraging reliance on repeated awards without clear outcomes. At the same time, the legislation encouraged greater access for new and emerging businesses by promoting a more balanced distribution of funding opportunities. This approach aimed to maintain support for high-performing firms while reducing the potential for over-concentration and reinforcing the program’s core objective of fostering innovation across a diverse and competitive small business community.
Strategic Breakthrough Allocation
Something new reauthorization brings to the table is the Strategic Breakthrough Allocation for companies who have successfully completed a Phase II with an eligible agency. This funding is only available in agencies whose extramural R & D budgets surpass $100 million.
Intending to help scale critical technologies quicker by bridging the gap between early-stage research and commercialization, large agencies can spend up to $30 million of their budget for projects with strong potential for transformative outcomes. The technology being funded must be 1) commercially viable and 2) validated by market research. In addition, companies must secure 100% matching funds from private capital or non-SBIR government sources.
Begin Your SBIR/STTR Application Journey
Following the enactment of the Small Business Innovation and Economic Security Act, multiple federal agencies have begun opening SBIR/STTR application opportunities, expanding access across a broader innovation landscape. The Department of War led the initial release, with additional agencies quickly following, and more announcements are anticipated. Upcoming updates will provide detailed information on agency-specific funding opportunities and application timelines.
For guidance on SBIR/STTR programs or to begin your application, connect with us!